# A Single Dose Pharmacokinetics (PK) Study of GSK2434735 in Healthy Male Volunteers

> **NCT01563042** · PHASE1 · COMPLETED · sponsor: **GlaxoSmithKline** · enrollment: 5 (actual)

## Conditions studied

- Asthma

## Interventions

- **DRUG:** Intravenous (IV) single dose
- **DRUG:** Subcutaneous (SC) single dose

## Key facts

- **NCT ID:** NCT01563042
- **Lead sponsor:** GlaxoSmithKline
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2012-02-13
- **Primary completion:** 2012-05-23
- **Final completion:** 2012-05-23
- **Target enrollment:** 5 (ACTUAL)
- **Last updated:** 2017-06-20


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01563042

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01563042, "A Single Dose Pharmacokinetics (PK) Study of GSK2434735 in Healthy Male Volunteers". Retrieved via AI Analytics 2026-06-16 from https://api.ai-analytics.org/clinical/NCT01563042. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*